Home
>
US Stocks
>
Evelo Biosciences Inc
Evelo Biosciences Inc
EVLO

Evelo Biosciences Inc

$7.9719.41%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
8.07
Today Low/High
7.71 / 8.09
52 Week Low/High
$3.82 / $19.93
Market Cap
$498.21M

Company Details

Evelo Biosciences is a clinical stage biotechnology company developing orally delivered product candidates that are designed to act on the small intestinal axis, SINTAX™, with systemic therapeutic effects. SINTAX plays a central role in governing the immune, metabolic, and neurological systems. The Company's first product candidates are pharmaceutical preparations of single strains of microbes selected for the potential to offer defined pharmacological properties. Evelo's therapies have the potential to be effective, safe, and affordable medicines to improve the lives of people with inflammatory diseases and cancer.
Organisation
Evelo Biosciences Inc
Employees
2.02K
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Evelo Biosciences Inc share price today

Can Indians buy Evelo Biosciences Inc shares?

How can I buy Evelo Biosciences Inc shares from India?

Can Fractional shares of Evelo Biosciences Inc be purchased?

What are the documents required to start investing in Evelo Biosciences Inc stocks?

We are a SEBI registered investement advisor